Chairman of the Board
Pekka Mattila is a board member of Herantis since 2013. Currently CEO of Desentum, Pekka Mattila was the founding CEO of Finnzymes for 25 years until its acquisition by Thermo Fisher Scientific in 2010. Currently Mattila is the CEO of Desentum Oy and a board member in e.g. Fimmic Oy:n, Oy Medix Biochemia Ab:n and FIMM.